Shubin Hong

机构：Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University · ORCID：0000-0001-5377-7727

发表论文 66 篇 · 总被引 1312 次 · h-index 21

代表论文

• Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma (2025 · JAMA · 被引 73)
• Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trial (2025 · Cancer Cell · 被引 40)
• Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma (2025 · JAMA · 被引 29)
• CircGLIS3 inhibits thyroid cancer invasion and metastasis through miR-146b-3p/AIF1L axis (2023 · Cellular Oncology · 被引 19)
• Intense simplified strategy for newly diagnosed type 2 diabetes in patients with severe hyperglycaemia: multicentre, open label, randomised trial (2024 · BMJ · 被引 18)
• Adjuvant PD-1 blockade with camrelizumab in high-risk locoregionally advanced nasopharyngeal carcinoma (DIPPER): A multicenter, open-label, phase 3, randomized controlled trial. (2024 · Journal of Clinical Oncology · 被引 17)